Brian L. VanderBeek, MD, MPH, MSCE

He/Him
Ophthalmology
Accepting new patients
Sees patients age 18 and up
Scheie Eye Institute Penn Presbyterian
View 1 additional location
Make an appointmentCall 215-662-8100
Headshot of Brian L. VanderBeek, MD, MPH, MSCE
Penn Medicine Provider

About me

  • Associate Professor of Ophthalmology at the Hospital of the University of Pennsylvania

My education and training

  • Medical School: University of Cincinnati College of Medicine
  • Residency: The Christ Hospital
  • Residency: NewYork-Presbyterian/Weill Cornell Medical Center
  • Fellowship: University of Michigan W.K. Kellogg Eye Center

Spoken languages

English
English

Reviews

Average Rating

1120 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
May 2026
brian vanderbeek is very bright exudes confidence and very kind and professional
Anonymous
May 2026
he is very good doctor
Anonymous
May 2026
just very personable and attentive.
Anonymous
May 2026
very complete with his examination

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. VanderBeek is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Caplash S, Wahba J, VanderBeek BL Endophthalmitis Rates After Macular Hole and Epiretinal Membrane Surgery: A Multicenter TriNetX Study , Retina Society Annual Meeting: 2026

Tsui JC, VanderBeek BL Partnering to Improve Pickleball Ocular Safety Awareness , JAMA Ophthalmol: 2026,EPUB ahead of print

Frederik Joelving Medical students are using a popular research tool to pump out misleading studies , Science: 2026

Caplash S, Wahba J, Yu Y, Cardillo S, Hubbard RA, VanderBeek BL Trends in prevalence and incidence of diabetic retinal disease in patients with type 1 and type 2 diabetes mellitus , J Diabetes Complications, 40(6): 2026

Parekh BJ, Stein JD, Abuzaitoun R, Andrews CA, Branham K, Milentijevic D, Narayanan D, Khan NW, Pershing S, Wang SY, Ahmad BU, Connor TB, Patnaik JL, Mathias M, Leys M, McMillan B, Amakiri N, Johnson TJ, Sun CQ, Duncan JL, Jayasundera KT; SOURCE consortium Decline of Visual Function and Risk of Legal Blindness With Age in RPGR -Associated Retinal Degeneration: A Multicenter Study , Clin Exp Ophthalmol, 54(4): 2026,482-91

Chebolu AP, Chen Y, Jin F, VanderBeek BL Risk of Ocular Hypertension With Intravitreal Triamcinolone Compared to the Dexamethasone Implant , J Vitreoretin Dis: 2026,EPUB ahead of print

Li Y, French DD, Chaudhury AS, Gaddam S, Andrews CA, Marwah S, Rivera AS, Zhou X, Evans CT, Bryar PJ, Stein JD; Sight Outcomes Research Collaborative (SOURCE) Consortium Evaluating Metrics Assessing Surgical Success in Patients Undergoing Cataract Surgery , JAMA Ophthalmol, 144(5): 2026,463-473

Cordisco AJ, Jin F, Hamedani AG, VanderBeek BL Risk of Noninfectious Uveitis Associated With Disease-Modifying Therapies for Multiple Sclerosis , Am J Ophthalmol, 288: 2026,199-206

Gibbons AB, Li X, Henderson AD; Sight Outcomes Research Collaborative Consortium The Association Between Anemia and Pseudotumor Cerebri , J Neuroophthalmol: 2026

Applebaum SS, Fu J, Bakhoum M, Deng Y, Nwanyanwu KH; Sight Outcomes Research Collaborative (SOURCE) Consortium Who Gets Panretinal Photocoagulation? National Patterns in Proliferative Diabetic Retinopathy Treatment , Ophthalmol Sci, 6(6): 2026

View all publications